Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer : vimarsana.com

Veteran biopharmaceutical executive brings over 30 years of financial, corporate strategy, transactional and business development experienceBOTHELL, Wash., May 22, 2023 -- Athira Pharma,... | May 22, 2023

Related Keywords

Washington , United States , Seattle , Mark Litton , Athira Pharma , Julie Rathbun , Massachusetts Institute Of Technology , Securities Exchange , Twitter , Facebook , Exchange Commission , Linkedin , Nasdaq , Mckinsey Co , Technology Associate At Morgan Stanley , Corporate Development At Amgen , Anderson School Of Management , Instagram , Head Of Corporate Development At Synlogic Inc , Athira Pharma Inc , Master Of Business Administration , Neuraltus Pharmaceuticals , Andrew Gengos , Chief Financial Officer , Chief Business Officer , Glenna Mileson , Chief Executive Officer , Cyteir Therapeutics , Immunocellular Therapeutics , Chief Operating Officer , Corporate Development , Vice President , Technology Associate , Morgan Stanley , Senior Engagement Manager , Business Administration , Chemical Engineering , Massachusetts Institute , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Media Contact , Nc Stock Exchange , News , Nformation , Ress Release , Eteran , Iopharmaceutical , Xecutive , Rings , Ver , 0 , Ears , F , Orporate , Transactional , Nd , Usiness , Evelopment , Ay , 023 , Thira Atha Us04746l1044 ,